Artera gets FDA clearance for AI breast cancer risk prediction tool
Artera
May 12, 2026
GMR Solutions Inc. has completed the acquisition of GMR Solutions, a healthcare services other business in Texas, for $500.0 million. GMR Solutions provides healthcare services and supports medical response operations, with services centered in Lewisville, Texas. The healthcare M&A rationale is to strengthen capital structure and fund corporate priorities through an initial public offering and related financing. The other acquisition is tied to a concurrent $500.0 million private placement, with net proceeds intended to redeem Series B preferred stock and repay first lien term loan borrowings due 2032. The IPO priced at $15.00 per share for 31,914,893 Class A shares, with NYSE trading expected May 13, 2026 under GMRS and a May 14, 2026 closing target.
Artera
May 12, 2026
Brightstar Capital Partners→Simon Eye
May 12, 2026
HealthScape Advisors→PayerAlly
May 12, 2026
Bora Biologics USA→MacroGenics
May 12, 2026
Travere Therapeutics
May 11, 2026